Bellevue Life Sciences Acquisition Corp. (BLAC) Stock Analysis

What Bellevue Life Sciences Acquisition Corp. does

Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.

Key metrics

ETFs linked to BLAC

Broad-market and Financial Services sector ETFs an investor holding Bellevue Life Sciences Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BLAC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Bellevue Life Sciences Acquisition Corp.?

Bellevue Life Sciences Acquisition Corp. trades under the ticker BLAC on NASDAQ.

Which exchange is BLAC listed on?

BLAC is listed on NASDAQ.

What sector does Bellevue Life Sciences Acquisition Corp. operate in?

Bellevue Life Sciences Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze BLAC in a portfolio?

PortView shows BLAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.